Netripples Software Ltd
₹ 5.51
0.00%
24 Jul 2023
About
Incorporated in 1993, Netripples Software Ltd provides Healthcare and Education Informatics[1]
Key Points
- Market Cap ₹ 3.76 Cr.
- Current Price ₹ 5.51
- High / Low ₹ /
- Stock P/E 25.1
- Book Value ₹ 14.6
- Dividend Yield 0.00 %
- ROCE 1.79 %
- ROE 1.79 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.38 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -14.9% over past five years.
- Promoter holding is low: 35.5%
- Company has a low return on equity of 0.64% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11.26 | 13.27 | 15.88 | 22.81 | 25.67 | 24.99 | 14.00 | 10.91 | 9.29 | 4.80 | 3.93 | 6.26 | 6.51 | |
11.20 | 12.33 | 14.88 | 21.51 | 24.47 | 24.05 | 13.91 | 10.81 | 9.20 | 4.74 | 3.87 | 6.03 | 6.28 | |
Operating Profit | 0.06 | 0.94 | 1.00 | 1.30 | 1.20 | 0.94 | 0.09 | 0.10 | 0.09 | 0.06 | 0.06 | 0.23 | 0.23 |
OPM % | 0.53% | 7.08% | 6.30% | 5.70% | 4.67% | 3.76% | 0.64% | 0.92% | 0.97% | 1.25% | 1.53% | 3.67% | 3.53% |
0.28 | 0.00 | 0.00 | -0.28 | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Interest | 0.26 | 0.23 | 0.28 | 0.49 | 0.45 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.05 | 0.09 | 0.34 | 0.24 | 0.26 | 0.28 | 0.07 | 0.09 | 0.08 | 0.05 | 0.04 | 0.08 | 0.08 |
Profit before tax | 0.03 | 0.62 | 0.38 | 0.29 | 0.42 | 0.47 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.15 | 0.15 |
Tax % | 33.33% | 1.61% | 2.63% | 0.00% | 7.14% | 6.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
0.02 | 0.61 | 0.38 | 0.28 | 0.39 | 0.44 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | 0.15 | 0.15 | |
EPS in Rs | 0.03 | 0.89 | 0.56 | 0.41 | 0.57 | 0.65 | 0.01 | 0.01 | 0.00 | 0.01 | 0.03 | 0.22 | 0.22 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -9% |
5 Years: | -15% |
3 Years: | -12% |
TTM: | 61% |
Compounded Profit Growth | |
---|---|
10 Years: | -9% |
5 Years: | 72% |
3 Years: | % |
TTM: | 25% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -10% |
3 Years: | 5% |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 0% |
3 Years: | 1% |
Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 |
Reserves | 0.55 | 1.16 | 1.55 | 2.20 | 2.59 | 3.03 | 3.04 | 3.05 | 3.05 | 3.06 | 3.08 | 0.00 |
1.58 | 1.57 | 2.52 | 3.83 | 2.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.29 | 0.30 | 0.31 | 0.31 | 0.45 | 0.42 | 0.31 | 0.30 | 0.30 | 0.26 | 0.25 | 0.57 | |
Total Liabilities | 9.24 | 9.85 | 11.20 | 13.16 | 12.73 | 10.27 | 10.17 | 10.17 | 10.17 | 10.14 | 10.15 | 7.39 |
0.24 | 0.40 | 0.50 | 0.28 | 0.31 | 0.20 | 0.64 | 0.54 | 0.42 | 0.20 | 0.13 | 0.48 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
9.00 | 9.45 | 10.70 | 12.88 | 12.42 | 10.07 | 9.53 | 9.63 | 9.75 | 9.94 | 10.02 | 6.91 | |
Total Assets | 9.24 | 9.85 | 11.20 | 13.16 | 12.73 | 10.27 | 10.17 | 10.17 | 10.17 | 10.14 | 10.15 | 7.39 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.69 | 1.64 | 3.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 | |||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Net Cash Flow | 0.00 | 0.00 | 0.69 | 1.64 | 3.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 14.59 | 14.30 | 24.59 | 26.08 | 16.35 | 15.48 | 15.38 | 13.72 | 11.79 | 20.53 | 21.36 | 19.24 |
Inventory Days | 4,150.71 | |||||||||||
Days Payable | 32.76 | |||||||||||
Cash Conversion Cycle | 14.59 | 14.30 | 24.59 | 26.08 | 16.35 | 15.48 | 4,133.33 | 13.72 | 11.79 | 20.53 | 21.36 | 19.24 |
Working Capital Days | 268.73 | 240.95 | 230.54 | 135.05 | 125.27 | 139.34 | 246.11 | 319.84 | 380.32 | 753.57 | 929.68 | 376.08 |
ROCE % | 9.19% | 6.46% | 7.48% | 5.96% | 0.20% | 0.10% | 0.10% | 0.10% | 0.20% | 1.79% |
Documents
Announcements
-
Updated March 2025 Financial Results
10h - Netripples reports Q4 FY25 unaudited results: Rs. 2.03 Cr revenue, Rs. 14.71 lakh net profit, limited review done.
-
Signed Audit Report For Financial Year 2024-25
9h - Auditor's report for FY 2024-25 confirms fair financials and effective internal controls, no material issues.
-
Updated Financial Results With Minor Corrections To Meet Format Requirements
10h - Netripples reports Q3 FY25 net profit of Rs 5.55 lakh; turnaround from prior year losses.
-
Updated June 2024 Qtr End Financial Results As Triggerred
10h - Netripples reports Q1 FY25 unaudited results: revenue Rs 95.68L, net profit Rs 3.18L, clean audit review.
-
Updated Financial Results With Minor Corrections Triggered For Quarter Ending 31-03-2024
15h - Netripples Software reports Q4 FY24 unaudited results with INR 146.57L revenue and INR 3.17L net profit.
Products & Services:[1]
Company's products and services are used in 20+ countries, 10 ministries of health and 3000+ Clients worldwide. It has 75 products and services in Healthcare Informatics and has the Only Store in the world which has the DIOMS (Downloadable, Instantaneous Installations, Operate, Maintenance and Services and Support Online). These include:
a) Ready to use Healthcare Informatics products
b) Consulting on Blood Bank and Blood Bank Networking and Standard Operating procedures
c) Outsourcing on Healthcare and Education and Supply Chain Software Development, Maintenance and Support
d) Project Migration from Client Server Technologies to Web based Technologies,
Mobile Technologies, and Cloud based Environment Deployment services
e) Data Migration, Data Storage, Data Center Management and Infrastructure Services
f) Online and E-commerce Store Setup, Establishment, and Training and Deployments
g) Franchise Establishment and Channel network support and services for the Netripples Products and Services